Home » Beiträge » 10274

View Beitrag #10274

ID	10274
Ident	Banner BAK-Fortbildung MS-Therapie mit Teriflunomid
Titel	BAK-Fortbildung MS-Therapie mit Teriflunomid
Balkentitel	ZERTIFIZIERTE FORTBILDUNG
Created	2023-11-30 16:06:28
Veraltet	1
typ_id	Universal 2023
sub_typ_id	Banner
html	<table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/wissen/zertifizierte-fortbildungen/ms-therapie-mit-teriflunomid/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_ZertFobi_MS-Therapie-mit-Teriflunomid.jpg" alt="Zur BAK-Fortbildung MS-Therapie mit Teriflunomid" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="Zur BAK-Fortbildung MS-Therapie mit Teriflunomid"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Typo3Html	<table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/wissen/zertifizierte-fortbildungen/ms-therapie-mit-teriflunomid/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_ZertFobi_MS-Therapie-mit-Teriflunomid.jpg" alt="Zur BAK-Fortbildung MS-Therapie mit Teriflunomid" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="Zur BAK-Fortbildung MS-Therapie mit Teriflunomid"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>

Newsletter 2023

2023-12-01 2023-12-22

Beitrag per e-mail verschicken

Auswertungsvorlage anzeigen

Statistik anzeigen